BSE Live
Dec 11, 16:01Prev. Close
169.35
Open Price
169.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 11, 15:31Prev. Close
169.55
Open Price
169.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
168.23 (3816)
| Cash Flow of Suven Life Sciences (in Rs. Cr.) | Mar 15 | Mar 08 | Mar 07 | Mar 06 | Mar 05 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 151.55 | 6.36 | 10.76 | 6.49 | 5.79 | |
| Net CashFlow From Operating Activities | 142.91 | 3.94 | 16.24 | 5.51 | 2.11 | |
| Net Cash Used In Investing Activities | -110.45 | -16.20 | -20.46 | -9.45 | -4.11 | |
| Net Cash Used From Financing Activities | 179.13 | 5.52 | 12.62 | 2.73 | -7.51 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 211.59 | -6.74 | 8.40 | -1.20 | -9.51 | |
| Cash And Cash Equivalents Begin of Year | 67.77 | 9.78 | 1.37 | 2.57 | 12.09 | |
| Cash And Cash Equivalents End Of Year | 279.36 | 3.04 | 9.78 | 1.37 | 2.57 |
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y